These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15903254)

  • 1. Construction and evaluation of drug-metabolizing cell line for bioartificial liver support system.
    Omasa T; Kim K; Hiramatsu S; Katakura Y; Kishimoto M; Enosawa S; Ohtake H
    Biotechnol Prog; 2005; 21(1):161-7. PubMed ID: 15903254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term culture of glutamine synthetase-transfected HepG2 cells in circulatory flow bioreactor for development of a bioartificial liver.
    Enosawa S; Miyashita T; Suzuki S; Li XK; Tsunoda M; Amemiya H; Yamanaka M; Hiramatsu S; Tanimura N; Omasa T; Suga K; Matsumura T
    Cell Transplant; 2000; 9(5):711-5. PubMed ID: 11144971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bioreactor with CYP3A4- and glutamine synthetase-introduced HepG2 cells: treatment of hepatic failure dog with diazepam overdosage.
    Wang N; Tsuruoka S; Yamamoto H; Enosawa S; Omasa T; Sata N; Matsumura T; Nagai H; Fujimura A
    Artif Organs; 2005 Aug; 29(8):681-4. PubMed ID: 16048486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significant improvement of survival times and pathological parameters by bioartificial liver with recombinant HepG2 in porcine liver failure model.
    Enosawa S; Miyashita T; Saito T; Omasa T; Matsumura T
    Cell Transplant; 2006; 15(10):873-80. PubMed ID: 17299991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo estimation of bioartificial liver with recombinant HepG2 cells using pigs with ischemic liver failure.
    Enosawa S; Miyashita T; Fujita Y; Suzuki S; Amemiya H; Omasa T; Hiramatsu S; Suga K; Matsumura T
    Cell Transplant; 2001; 10(4-5):429-33. PubMed ID: 11549067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ammonia metabolism capacity of HepG2 cells with high expression of human glutamine synthetase.
    Tang NH; Wang XQ; Li XJ; Chen YL
    Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):621-7. PubMed ID: 19073408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a bioartificial liver with glutamine synthetase-transduced recombinant human hepatoblastoma cell line, HepG2.
    Miyashita T; Enosawa S; Suzuki S; Tamura A; Tanaka H; Amemiya H; Matsumura T; Omasa T; Suga K; Aoki T; Koyanagi Y
    Transplant Proc; 2000 Nov; 32(7):2355-8. PubMed ID: 11120198
    [No Abstract]   [Full Text] [Related]  

  • 8. Human CYP3A4-introduced HepG2 cells: in vitro screening system of new chemicals for the evaluation of CYP3A4-inhibiting activity.
    Araki N; Tsuruoka S; Wang N; Hasegawa G; Yanagihara H; Ando H; Omasa T; Enosawa S; Nagai H; Fujimura A
    Xenobiotica; 2008 Nov; 38(11):1355-64. PubMed ID: 18846481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An attempt to add biological functions by genetic engineering in order to produce high-performance bioreactor cells for hybrid artificial liver: transfection of glutamine synthetase into Chinese hamster ovary (CHO) cell.
    Enosawa S; Suzuki S; Fujino M; Amemiya H; Omasa T; Urayama S; Tanimura N; Suga K
    Cell Transplant; 1997; 6(5):537-40. PubMed ID: 9331509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased hepatic functionality of the human hepatoma cell line HepaRG cultured in the AMC bioreactor.
    Nibourg GA; Hoekstra R; van der Hoeven TV; Ackermans MT; Hakvoort TB; van Gulik TM; Chamuleau RA
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1860-8. PubMed ID: 23770120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable overexpression of arginase I and ornithine transcarbamylase in HepG2 cells improves its ammonia detoxification.
    Tang N; Wang Y; Wang X; Zhou L; Zhang F; Li X; Chen Y
    J Cell Biochem; 2012 Feb; 113(2):518-27. PubMed ID: 21938740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of carbamoyl phosphate synthetase 1 reporter cell lines for the assessment of ammonia metabolism.
    Wang Y; Chang L; Zhai J; Wu Q; Wang D; Wang Y
    J Cell Mol Med; 2017 Dec; 21(12):3214-3223. PubMed ID: 28557353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methionine sulfoximine supplementation enhances productivity in GS-CHOK1SV cell lines through glutathione biosynthesis.
    Feary M; Racher AJ; Young RJ; Smales CM
    Biotechnol Prog; 2017 Jan; 33(1):17-25. PubMed ID: 27689785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HepaRG cell line is suitable for bioartificial liver application.
    Hoekstra R; Nibourg GA; van der Hoeven TV; Ackermans MT; Hakvoort TB; van Gulik TM; Lamers WH; Elferink RP; Chamuleau RA
    Int J Biochem Cell Biol; 2011 Oct; 43(10):1483-9. PubMed ID: 21726661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioartificial liver.
    Poyck PP; van Wijk AC; van der Hoeven TV; de Waart DR; Chamuleau RA; van Gulik TM; Oude Elferink RP; Hoekstra R
    J Hepatol; 2008 Feb; 48(2):266-75. PubMed ID: 18093687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolism of recombinant CHO-GS cell reducing of toxic effect of ammonia].
    Zhang F; Yi XP; Sun XM; Zhang YX
    Sheng Wu Gong Cheng Xue Bao; 2006 Jan; 22(1):94-100. PubMed ID: 16572847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a highly-efficient CHO cell line generation system with engineered SV40E promoter.
    Fan L; Kadura I; Krebs LE; Larson JL; Bowden DM; Frye CC
    J Biotechnol; 2013 Dec; 168(4):652-8. PubMed ID: 23994266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the efficiency of CHO cell line generation using glutamine synthetase gene knockout cells.
    Fan L; Kadura I; Krebs LE; Hatfield CC; Shaw MM; Frye CC
    Biotechnol Bioeng; 2012 Apr; 109(4):1007-15. PubMed ID: 22068567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolongation of survival of pigs with ischemic liver failure by treatment with a bioartificial liver using glutamine synthetase transfected recombinant HepG2.
    Enosawa S; Miyashita T; Tanaka H; Li X; Suzuki S; Amemiya H; Omasa T; Suga K; Matsumura T
    Transplant Proc; 2001; 33(1-2):1945-7. PubMed ID: 11267581
    [No Abstract]   [Full Text] [Related]  

  • 20. Stable overexpression of pregnane X receptor in HepG2 cells increases its potential for bioartificial liver application.
    Nibourg GA; Huisman MT; van der Hoeven TV; van Gulik TM; Chamuleau RA; Hoekstra R
    Liver Transpl; 2010 Sep; 16(9):1075-85. PubMed ID: 20818746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.